Login
Zhengye Biotechnology Holding Ltd logo

Zhengye Biotechnology Holding Ltd

ir.jlzybio.com

What Do They Do?

Manufactures and sells veterinary vaccines, mainly for livestock, to farmers, local governments and distributors.

How Do They Make Money?

The company sells veterinary vaccines; distributors pay before delivery, and sales are counted when customers accept the goods.

FY2025 revenue by product or service (Revenues generated from different product categories) revenue
SegmentShareRevenue
Swine vaccines
77%
Poultry vaccines
11%
Other vaccines
12%
Direct sales channel
45%
FY2022: 80%
Distribution network
53%
FY2022: 18%
Government tender and procurement
2.5%
FY2022: 2.0%

Who Are Their Customers?

Livestock farmers and local governments buy directly, while domestic and overseas distributors resell the vaccines. Direct sales also reach major breeding companies through tenders and contracts with breeders.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2023: 67% from two customers

Do Revenues Turn Into Profits?

Not on paper. It lost CNY 69.8M in FY2025, but brought in more cash than it spent: CNY 12.3M of free cash flow.

Operating income, FY2025
−61% of revenue
▼ Turned to a loss vs FY2024 (CNY 16.4M, 9%)
Net income, FY2025
−60% of revenue
▼ Turned to a loss vs FY2024 (CNY 11.3M, 6%)
Free cash flow, FY2025
11% of revenue
▼ −55% vs FY2024 (CNY 27.5M, 15%)

How Are They Changing?

Revenue over time
Swine vaccines Poultry vaccines Other vaccines Direct sales channel Distribution network Government tender and procurement
$500M$250M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support